We investigated the incidence and severity of echocardiographic and clinical abnormalities in patients with psoriasis and their relationship to the severity, duration and type of psoriasis and other related factors. A total of 216 psoriasis patients and 216 control subjects were included in this study. Left and right heart dimensions, wall thicknesses, wall motion abnormalities, valvular disturbances, and systolic and diastolic functions were examined using two-dimensional and Doppler echocardiographic techniques. Left ventricular hypertrophy, left ventricular diastolic dysfunction, left ventricular wall motion abnormalities and valvular pathologies, especially mitral and tricuspid valve prolapse, were significantly more frequent in patients with psoriasis. Systolic and diastolic blood pressures were significantly higher in psoriasis patients. Significant correlations were found between: (i) psoriasis vulgaris and tricuspid valve prolapse; (ii) palmo-plantar psoriasis and valvular pathologies; and (iii) disease duration and left ventricular diastolic dysfunction and systolic and diastolic blood pressures. Physicians should be aware that cardiovascular abnormalities are common in patients with psoriasis.
Introduction
Psoriasis is a common, chronic skin disease that is characterized by various clinical manifestations, and is relapsing, disfiguring, inflammatory and proliferative in nature. 1, 2 Psoriasis is a systemic disease with immunological and genetic determinants. Macrovascular and microvascular changes have been shown to be involved in the pathogenesis of the disease. 1, 2 The prevalence of psoriasis is very high in the general population. For example, in the USA the disease affects about 2% of the population. 1, 2 In general, the incidence of the disease has been reported to be between 1.5% and 3%. 1, 2 The skin lesions associated with psoriasis may be disabling, but patients might also experience the concomitant joint disease of psoriatic arthritis. Psoriatic arthritis is the only defined non-cutaneous manifestation of the disease and it affects around 10% of wellestablished psoriasis cases. 3 Cardiovascular disorders such as hypertension, dyslipidaemia, coronary heart disease and heart failure have been reported to occur more frequently in psoriasis cases than in the general population. 4 -6 Associations among heart disease, psoriasis and psoriatic arthritis have been reported in some studies. 7 -9 Myocardial and valvular I Biyik, A Narin, MA Bozok et al.
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pathologies associated with psoriasis have also been reported. 10, 11 However, there have been few reports to date in the Englishlanguage literature.
In this study, we aimed to (i) determine the incidence and severity of any echocardiographic and clinical abnormalities in patients with psoriasis; and (ii) investigate the relationships of any such abnormalities with the severity and type of the disease and with other related factors, such as blood pressure, age and gender of the patient.
Patients and methods

PATIENT POPULATION
This study was planned and conducted in Uşak State Hospital (Uşak, Turkey) in collaboration with the Department of Cardiology of Atatürk Education and Training Hospital (Izmir, Turkey). The study protocol and informed consent form were approved by the Institutional Review Board of Atatürk Education and Training Hospital. All patients and control subjects included in this study provided informed consent.
Patients diagnosed with psoriasis and age-and sex-matched control subjects diagnosed with pityriasis versicolor were enrolled in the study. The diagnosis of psoriasis was made using both a dermatological examination and a punch biopsy. The Psoriasis Area Severity Index (PASI) was calculated in all psoriasis cases. All patients and controls were evaluated using echocardiography and a physical examination, and each subject provided a detailed medical history.
Patients having known coronary artery disease, heart failure, diabetes mellitus, thyroid disorder, hypertension, obesity, connective tissue disorder, hepatic dysfunction, renal failure and patients with psoriatic arthritis were excluded from the study.
ECHOCARDIOGRAPHIC MEASUREMENTS
All measurements were made using an echocardiograph with a 2.0 MHz probe (Vivid ® 3; GE Medical Systems, Milwaukee, Wisconsin, USA) according to the American College of Cardiology/American Heart Association (ACC/AHA) echocardiography guidelines 12 and the American Society of Echocardiography recommendations for the use of echocardiography in clinical trials. 13 To obtain true left ventricular linear measurements, the left ventricular dimensions, and septal and posterior wall thicknesses were measured from the parasternal long-axis window. The diagnosis of mitral valve prolapse was also established from the parasternal long-axis window according to guideline recommendations. 1, 2 Left ventricular wall motion abnormalities and Doppler measurements of diastolic functions were performed using the apical windows. Left ventricular dilatation limits were taken to be measurements above 5.5 cm and 5.8 cm for women and men, respectively. The lower limit for left ventricular hypertrophy was 1.2 cm for both genders. Left ventricular ejection fraction was measured by the biplane volume measurement method using the apical fourand two-chamber view, and these measurements were checked against the measurements obtained by visual inspection. The right ventricular dimensions and free wall thickness were measured in the apical four-chamber view at the level of the left ventricular papillary muscles. The limits of right ventricular dilatation and hypertrophy were taken to be measurements above 3.7 cm and 0.7 cm, respectively for both genders. All measurements were evaluated according to the recommendations of the American Society of Echocardiography for chamber quantification. 14 
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inflow measurements, such as early filling velocity (E peak), late filling velocity (A peak), E/A ratios, early filling velocity deceleration time and isovolumetric relaxation time, and tricuspid valve inflow measurements, such as E peak, A peak, E/A ratios and other valve velocities, were calculated from Doppler measurements according to guideline recommendations. 15 
STATISTICAL ANALYSIS
Descriptive statistics were provided for the numerical and categorical variables using mean ± SD and percentage distribution where appropriate. Sub-group analyses used the Mann-Whitney U-test; for normal distributions the Student's t-test was used to compare numerical variables across groups. The χ 2 test and Fisher's test were used to compare percentage distributions across levels of nominal variables. The Pearson correlation was used to assess the relationship between numerical variables, and the Spearman correlation was used to measure the relationship between categorical variables. P-values < 0.05 were considered to be statistically significant.
Results
A total of 216 patients with psoriasis and 216 sex-and age-matched controls were included in the study. Table 1 presents the demographic characteristics of the psoriasis patients and control subjects. Patients with psoriasis had a mean duration of disease of 104 ± 131 months (range 1 -780 months) and a mean PASI score of 25 ± 16 (range 1.8 -60). Table 2 shows the two-dimensional and Doppler echocardiographic measurements for patients and control subjects. Left ventricular diastolic dysfunction was found in 60 psoriasis patients (27.8%) and 30 controls (13.9%) (P < 0.001), all of whom showed phase 1 diastolic dysfunction. Right ventricular diastolic dysfunction was found in six psoriasis patients (2.8%) and two controls (0.9%); the difference was not statistically significant. Left ventricular wall motion abnormalities were seen in 30 psoriasis patients (13.9%) and 11 controls (5.1%) (P = 0.002). Left ventricular hypertrophy was found in 24 psoriasis patients (11.1%) and 10 controls (4.6%) (P = 0.01).
Valvular disturbances were observed in 88 psoriasis patients (40.7%) and 39 controls (18.1%) (P < 0.001). The significance and types of valvular pathologies are shown in Table 3 . Pericardial effusions and pericarditis were seen in two psoriasis patients (0.9%) and none of the controls; the difference was not significant. Inter-atrial septal aneurysm was seen in eight psoriasis patients (3.7%) and 10 controls (4.6%); the difference was not significant. In this study, we found no association between echocardiographic and clinical abnormalities and the PASI scores of the patients.
The distribution of the types of psoriasis found in patients included in this study was as I Biyik, A Narin, MA Bozok et al.
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follows: psoriasis vulgaris, 148 patients; psoriasis guttata, 32 patients; generalized psoriasis, 20 patients; and palmo-plantar psoriasis, 16 patients. A significant correlation was found between psoriasis vulgaris and tricuspid valve prolapse (P = 0.03). Another significant correlation was found between palmo-plantar psoriasis and valvular pathologies (P = 0.017). A longer disease duration was significantly associated with (i) a higher incidence of left ventricular diastolic dysfunction (P < 0.001); (ii) a higher systolic blood pressure (P < 0.001); and (iii) a higher diastolic blood pressure (P < 0.001). There were no significant associations between psoriasis disease duration and other echocardiographic and clinical abnormalities demonstrated in this study.
Discussion
The cardiac pathologies associated with psoriasis have been described in previous reports. 4 -6 Valvular pathologies such as aortic regurgitation and mitral valve prolapse, dilated cardiomyopathy, heart failure, aortitis, sudden death, angina pectoris and acute myocardial infarction have been reported in patients with psoriasis and psoriatic arthritis. 16 -20 This large-scale study revealed that left ventricular hypertrophy, left ventricular diastolic dysfunction, left ventricular wall motion abnormalities and valvular pathologies, especially mitral valve prolapse and tricuspid valve prolapse, are significantly more common in patients with psoriasis than control subjects. Systolic and diastolic blood pressures are also higher in psoriasis patients than in control subjects. The high incidence of tricuspid valve prolapse in patients with psoriasis was first demonstrated in this study. Significant correlations were found (i) between psoriasis disease duration and high blood pressure and left ventricular diastolic dysfunction; 
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(ii) between psoriasis vulgaris and tricuspid valve prolapse; and (iii) between palmoplantar psoriasis and valvular pathologies. Two patients with psoriasis had pericarditis, but the difference between psoriasis patients and control subjects in the frequency of pericarditis was not significant.
In a smaller study, Guven et al. 7 showed that the incidences of left ventricular diastolic dysfunction and mitral valve prolapse were higher in 62 psoriasis cases compared with healthy controls. Our study suggests that blood pressure levels were significantly higher in psoriasis patients than in controls. In our study, this finding might partly explain the higher incidence of left ventricular diastolic dysfunction, which may cause heart failure in these patients. The pathophysiology of heart failure in patients with normal ejection fraction may be heterogeneous, but in most cases heart failure is caused mainly by diastolic dysfunction. 21 Saricaoglu et al. 8 have suggested that mild left ventricular diastolic dysfunction may be seen in patients with psoriatic arthropathy. Their study also showed that the presence of left ventricular diastolic dysfunction was significantly related to the duration of the disease. 8 A longer disease duration of psoriasis was related to higher blood pressure and a higher incidence of diastolic dysfunction in our study. Our results were therefore consistent with those of the previous study. 8 Our study also demonstrated a higher incidence of left ventricular hypertrophy in patients with psoriasis, which might have been associated with the higher blood pressures found in psoriasis patients than in controls. Whether high blood pressure levels in patients with psoriasis predisposes them to develop hypertension and left ventricular hypertrophy requires further investigation. Hypertension predisposes to sudden death caused by left ventricular hypertrophy. The presence of left ventricular hypertrophy was associated with a 5-year mortality rate of 33% in men and 21% in women. 22 The risk of sudden death in the presence of left ventricular hypertrophy was comparable to that of coronary artery disease or heart failure. 23 Left ventricular hypertrophy identified by echocardiography may increase the risk of sudden cardiac death and pose an additional risk for patients with psoriasis.
No association was found between the clinical and echocardiographic abnormalities revealed in this study and the PASI scores of the patients. Badokin and Kotel'nikova 9 recently reported that myocarditis, pericarditis, valvular defects and aortitis were seen in patients with psoriatic arthropathy. Their results also showed that aortitis was detected in 51% of patients with advanced sacroiliitis and ankylosing spondylitis and that heart abnormalities were associated with spinal lesions, activity of the disease and, to a lesser degree, with the presence of the HLA-B27 gene. 9 Our study also showed valvular pathologies and pericarditis, but we were not able to demonstrate any cases of aortitis and myocarditis. However, psoriatic arthritis cases were excluded from our study. Moreover, the diagnosis of aortitis based only on electrocardiogram, X-ray and echocardiography may have caused some overestimation in the study of Badokin and Kotel'nikova. 9 In a previous study, Pines et al. 16 demonstrated a higher incidence of mitral valve prolapse and no aortic valve lesions in patients with psoriatic arthritis. Our study showed a high incidence of mitral valve prolapse and also tricuspid valve prolapse in patients with psoriasis. It is well known that mitral valve prolapse may cause arrhythmia, sudden death, significant mitral regurgitation I Biyik, A Narin, MA Bozok et al.
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and heart failure over time. 24 In an autopsy study of psoriasis patients, Kakturskii et al. 10 reported wall thickening of the microcirculatory vessels, and mononuclear cell proliferation, plasmatic impregnation and focal stromal sclerosis were observed in the myocardium. There was also disorganization of the connective tissue with mucoid oedema and diffuse mononuclear cell infiltration of the mitral and aortic valves. 10 These changes in the myocardium and heart valve tissues might suggest chronic, slowly progressing myocarditis and valvulitis. We also demonstrated that regional left ventricular wall motion abnormalities were significantly more common in patients with psoriasis than in control subjects. There are also reports of secondary amyloid depositions in the myocardial interstitium, intramyocardial small vessels, cardiac conduction system and other heart structures. 25, 26 These changes might also partly explain the frequently observed echocardiographic abnormalities in patients with psoriasis, such as mitral and tricuspid valve prolapse, regional wall motion abnormalities, hypertrophy and left ventricular diastolic dysfunction.
Patients with psoriasis also show lipid profile disturbances, such as increased cholesterol, triglycerides, low-density lipoprotein cholesterol, apolipoprotein B and lipoprotein (a) levels and a reduced high-density lipoprotein cholesterol level, so psoriasis might also be associated with additional risk factors for coronary artery disease. 27, 28 Our results support the view that psoriasis also involves the cardiovascular system and heart, and causes disturbances such as high blood pressure, left ventricular hypertrophy, regional wall motion abnormalities, diastolic dysfunction, and mitral and tricuspid valve prolapse. These cardiovascular abnormalities might expose psoriasis patients to an increased risk of cardiovascular morbidity and mortality. Therefore, dermatologists and cardiologists should be aware of the cardiovascular manifestations of psoriasis and keep in mind that cardiovascular abnormalities are common in this disease.
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